Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;268(6):2023-2025.
doi: 10.1007/s00415-020-10015-1. Epub 2020 Jun 25.

COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis

Vittorio Mantero  1 , Lucia Abate  2 , Paola Basilico  3 , Roberto Balgera  3 , Andrea Salmaggi  3 , Bardia Nourbakhsh  4 , Christian Cordano  5
Affiliations

COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis

Vittorio Mantero et al. J Neurol. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

VM, LA, and RB served in advisory boards and/or received travel grant from Biogen for participation at congress. PB, AS, BN, and CC have no conflict of interest to disclose.

References

    1. Foerch C, Friedauer L, Bauer B, Wolf T, Adam EH. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Mult Scler Relat Disord. 2020;42:102180. doi: 10.1016/j.msard.2020.102180. - DOI - PMC - PubMed
    1. Suwanwongse K, Shabarek N. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab. Mult Scler Relat Disord. 2020;42:102201. doi: 10.1016/j.msard.2020.102201. - DOI - PMC - PubMed
    1. Montero-Escribano P, Matías-Guiu J, Gómez-Iglesias P, Porta-Etessam J, Pytel V, Matias-Guiu JA. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain. Mult Scler Relat Disord. 2020;42:102185. doi: 10.1016/j.msard.2020.102185. - DOI - PMC - PubMed
    1. Safavi F, Nourbakhsh B, Azimi AR. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. Mult Scler Relat Disord. 2020;43:102195. doi: 10.1016/j.msard.2020.102195. - DOI - PMC - PubMed
    1. Novi G, Mikulska M, Briano F, et al. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? Mult Scler Relat Disord. 2020;42:102120. doi: 10.1016/j.msard.2020.102120. - DOI - PMC - PubMed